# Delivery Order #SPE2DR26FER5A

NovoLog Insulin Delivery Order Supports Federal Pharmaceutical Supply

**Buyer:** Defense Logistics Agency

**Award Amount:** $17,979.74
**Ceiling:** $17,979.74

**Awarded:** August 04, 2026
**Period of Performance:** Aug 04, 2026 - Aug 05, 2026

**Identifier:** SPE2DR26FER5A
**NAICS:** 424210

This delivery order is issued under a long-term pharmaceutical supply contract held by AmerisourceBergen Drug Corporation, a pharmaceutical sourcing and distribution company. It procures NovoLog insulin in prefilled FlexPen devices for the federal supply chain, supporting access to an essential diabetes medication. The scope is a short-term product purchase for delivery in Conshohocken, Pennsylvania. The parent contract is an indefinite-delivery vehicle running over a multi-year period; the order itself covers a brief delivery window. The available data does not identify whether this order was competitively awarded or sole-source, nor does it provide solicitation details, acquisition programs, subcontractors, or related earlier contracts.

### Description

4572580814!NOVOLOG 100 UNIT/ML FLEXPEN 3ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FER5A_9700_SPE2DR25D1100_9700)
